Keywords: genentech, start, trials, her-2, california, biotechnology, concern

GENENTECH TO START TRIALS OF HER-2

Article | 27 January 1992

- California's biotechnology concern Genentech reports that it will begin clinical trials with its HER-2 humanized monoclonal antibody anticancer product during ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genentech

Go to company listing

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Humulin 70-30

Insulin

Go to drug listing